EnGene Holdings Correlations

ENGN Etf  USD 6.78  0.49  6.74%   
The current 90-days correlation between enGene Holdings Common and Amylyx Pharmaceuticals is 0.19 (i.e., Average diversification). A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as EnGene Holdings moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if enGene Holdings Common moves in either direction, the perfectly negatively correlated security will move in the opposite direction.
  
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in enGene Holdings Common. Also, note that the market value of any etf could be closely tied with the direction of predictive economic indicators such as signals in price.

Moving together with EnGene Etf

  0.68DTIL Precision BioSciencesPairCorr
  0.65VIGL Vigil NeurosciencePairCorr
  0.61VKTX Viking Therapeutics Earnings Call This WeekPairCorr
  0.7VRCA Verrica PharmaceuticalsPairCorr

Moving against EnGene Etf

  0.74CDIOW Cardio DiagnosticsPairCorr
  0.47DRTS Alpha Tau MedicalPairCorr
  0.42VCEL Vericel Corp OrdPairCorr
  0.37DMAC DiaMedica TherapeuticsPairCorr
  0.34VCYT VeracytePairCorr
  0.46VRNA Verona Pharma PLCPairCorr
  0.39DYAI Dyadic InternationalPairCorr
  0.35SRZNW Surrozen WarrantPairCorr
  0.34DVAX Dynavax TechnologiesPairCorr

Related Correlations Analysis

Click cells to compare fundamentals   Check Volatility   Backtest Portfolio

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.
High positive correlations   
XOMF
XOMUBER
AMETA
JPMA
CRMT
FUBER
  
High negative correlations   
CRMUBER
XOMMETA
MRKJPM
FMETA
XOMMSFT
UBERMSFT

EnGene Holdings Competition Risk-Adjusted Indicators

There is a big difference between EnGene Etf performing well and EnGene Holdings ETF doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze EnGene Holdings' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
META  1.41  0.26  0.13  0.73  1.40 
 3.43 
 7.43 
MSFT  1.12 (0.03) 0.00 (0.42) 0.00 
 2.20 
 7.31 
UBER  1.56 (0.23) 0.00 (3.08) 0.00 
 2.67 
 12.29 
F  1.47 (0.18) 0.00 (0.20) 0.00 
 2.57 
 11.21 
T  1.00  0.10  0.04  0.30  1.08 
 1.91 
 7.94 
A  1.20  0.19  0.11  0.48  1.06 
 2.92 
 8.06 
CRM  1.51  0.34  0.15  2.71  1.42 
 3.70 
 14.80 
JPM  1.05  0.25  0.15  0.96  1.05 
 1.92 
 15.87 
MRK  1.03 (0.11) 0.00 (0.43) 0.00 
 2.00 
 5.24 
XOM  0.82 (0.16) 0.00 (0.28) 0.00 
 1.71 
 6.06